Breaking News Instant updates and real-time market news.

FB

Facebook

$180.08

(0.00%)

, BABA

Alibaba

$177.65

(0.00%)

09:44
08/14/18
08/14
09:44
08/14/18
09:44

Jana Partners buys Facebook and Alibaba in Q2, sells out of Northrop

Barry Rosenstein's Jana Partners disclosed in a regulatory filing its holdings as of June 30, 2018. Jana made 23 new buys during the first quarter, including, by size of position, Facebook (FB), Alibaba (BABA), Microsoft (MSFT), Wells Fargo (WFC) and Alphabet Class A (GOOGL). Jana exited 16 positions during the quarter, including by size of previous position, Bloomin' Brands (BLMN), Northrop Grumman (NOC), Keurig Dr Pepper (KDP), WestRock (WRK) and Cigna (CI). Jana increased its stake in six holdings, including by size, Pinnacle Foods (PF), Electronic Arts (EA), Agilent Technologies (A) and Apple (AAPL). The fund reduced its stake in nine holdings, including by size Tiffany (TIF), Lam Research (LRCX), HD Supply Holdings (HDS), Autodesk (ADSK) and Boston Scientific (BSX). Jana's top holdings as of June 30, in order of size, were Pinnacle Foods, Zimmer Biomet (ZBH), HD Supply, Tiffany and Jack in the Box (JACK).

FB

Facebook

$180.08

(0.00%)

BABA

Alibaba

$177.65

(0.00%)

MSFT

Microsoft

$108.24

(0.00%)

WFC

Wells Fargo

$57.64

(0.00%)

GOOGL

Alphabet Class A

$1,248.76

(0.00%)

GOOG

Alphabet

$1,235.10

(0.00%)

BLMN

Bloomin' Brands

$18.13

(0.00%)

NOC

Northrop Grumman

$292.10

(0.00%)

KDP

Keurig Dr Pepper

$23.75

(0.00%)

WRK

WestRock

$54.73

(0.00%)

CI

Cigna

$181.78

(0.00%)

EA

Electronic Arts

$131.29

(0.00%)

A

Agilent

$65.95

(0.00%)

AAPL

Apple

$208.87

(0.00%)

TIF

Tiffany

$130.88

(0.00%)

LRCX

Lam Research

$178.13

(0.00%)

HDS

HD Supply

$43.72

(0.00%)

ADSK

Autodesk

$133.41

(0.00%)

BSX

Boston Scientific

$33.30

(0.00%)

ZBH

Zimmer Biomet

$122.45

(0.00%)

JACK

Jack in the Box

$89.03

(0.00%)

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 15

    Aug

  • 15

    Aug

  • 19

    Aug

  • 20

    Aug

  • 21

    Aug

  • 22

    Aug

  • 23

    Aug

  • 23

    Aug

  • 23

    Aug

  • 24

    Aug

  • 28

    Aug

  • 04

    Sep

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 12

    Sep

  • 12

    Sep

  • 13

    Sep

  • 28

    Oct

  • 06

    Nov

  • 12

    Apr

  • 13

    Jul

  • 12

    Oct

FB Facebook
$180.08

(0.00%)

08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
08/08/18
CHLM
08/08/18
NO CHANGE
Target $28
CHLM
Sell
Applied Optoelectronics price target raised to $28 from $20 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Applied Optoelectronics (AAOI) to $28 from $20 following a "strong" Q2 result, driven by strong upside from Data Center, specifically Facebook (FB). The analyst thinks most of the upside was from lack of supply from a competitor he believes to be Intel (INTC). He reiterates a Sell rating on Applied Optoelectronics shares.
08/09/18
BMOC
08/09/18
NO CHANGE
Target $52
BMOC
Outperform
Match Group price target raised to $52 from $45 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Match Group (MTCH) to $52 after its Q2 earnings beat and raised FY18 guidance, saying its Tinder platform continues to exceed expectations while the rest of the portfolio shows stability. Salmon adds that Tinder's subscription growth and pricing power position Match Group as a "sustainable long-term" story within the expanding total addressable market, even as the entry of Facebook (FB) into the online dating industry gets closes. The analyst keeps his Outperform rating on Match Group.
08/06/18
STFL
08/06/18
NO CHANGE
Target $202
STFL
Buy
Facebook added to Stifel Select List, Amazon removed
Stifel analyst Scott Devitt replaced Amazon (AMZN) with Facebook (FB) on the Stifel Select List, citing the strong year-to-date performance of Amazon shares, which he still likes and keeps a Buy rating upon. He believes Facebook expectations, and the shares, are appropriately set to allow for longer-term outperformance given the material reset that followed the company's "painful" Q2 update, Devitt tells investors. He maintains a Buy rating and $202 price target on Facebook.
BABA Alibaba
$177.65

(0.00%)

07/06/18
RHCO
07/06/18
NO CHANGE
Target $215
RHCO
Buy
Alibaba price target lowered to $215 from $235 at SunTrust
SunTrust analyst Youssel Squali lowered his price target on Alibaba to $215, citing the impact of later than expected closing for Ele.me, whose $9.5B acquisition was announced in early April. The analyst is also tempering his expectations for growth in the Cloud segment while noting the adverse impact of the recent USD strength relative to the Renminbi. Longer term, Squali keeps his Buy rating on Alibaba, pointing to "exciting initiatives" around Ant Financial's new funding at $150B, exclusive online broadcasting rights of the World Cup, and promising initiatives around enterprise and voice.
08/14/18
MKMP
08/14/18
NO CHANGE
Target $51
MKMP
Buy
JD.com has 'improving event path' and 'low valuation', says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $51 price target on JD.com (JD) ahead of its Q2 earnings this week, saying that while consensus expectations suggest concern with whether net margins can achieve the 0.9%, more bullish investors can be rewarded beyond this quarter. The analyst further notes that the loss of market share to Alibaba (BABA), along with China macro trade concerns, have weighed on the stock, but its "all-time low" valuation is compelling, and even a partial recovery in performance could yield a sizable move in the stock price.
07/09/18
DADA
07/09/18
NO CHANGE
Target $8
DADA
Buy
Groupon offers 'tremendous value' in potential sale, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon following speculation by Recode over the weekend that the company is looking to sell itself. Forte recommends that investors purchase shares, stating that the market is underpricing Groupon as its "North American business has never been in better shape and its international operations are well positioned". In a bull case, the analyst contends that Groupon could be worth $12 per share if it can improve its growth rate or find a strategic buyer where a deal would value the two companies higher than the sum of their parts. Forte speculates about Priceline (PCLN), Alibaba (BABA), Google (GOOGL), and Facebook (FB) as potential acquirers for Groupon.
MSFT Microsoft
$108.24

(0.00%)

08/03/18
BARD
08/03/18
NO CHANGE
Target $2100
BARD
Outperform
Amazon summit highlights long cloud growth runway, says Baird
After having attended the AWS Summit in Chicago this week, Baird analyst Colin Sebastian said his talks with several enterprise IT decision makers highlight Amazon's "clear advantage" in product breadth and go-to-market capabilities despite the fact that cloud services competition is "undoubtedly intensifying" from Microsoft's (MSFT) Azure and Alphabet's (GOOGL) Google Cloud Platform. Most large-scale enterprises are still in the early days of cloud migration, which bodes well for the long-term growth outlook for AWS along with Azure and Google Cloud, Sebastian concluded. He keeps an Outperform rating and $2,100 price target on Amazon shares.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
07/27/18
OPCO
07/27/18
NO CHANGE
Target $120
OPCO
Outperform
Microsoft price target raised to $120 from $115 at Oppenheimer
Oppenheimer analyst Tim Horan raised his price target on Microsoft (MSFT) to $120 and maintained an Outperform rating, telling investors in a research note that he remains "bullish." With enterprises in the steepest part of the S-curve adoption cycle of cloud, over the next few quarters, he says he expects strong results from Azure which benefits from AWS (AMZN)/Google (GOOG, GOOGL) channel conflicts and also sees upside surprises in Gaming, Search, Dynamics, Hardware and strong operating leverage.
07/23/18
ARGS
07/23/18
NO CHANGE
Target $128
ARGS
Buy
Microsoft price target raised to $128 from $116 at Argus
Argus analyst Joseph Bonner raised his price target on Microsoft to $128 and kept his Buy rating after the company's "strong quarter" in Q4 and positive comments about FY19. The analyst believes the company is well positioned to grow its commercial revenue amid the accelerating digital transformation trend thanks to its "massive" user base and long-term relationships. Despite the run-up in the stock price, the analyst contends that Microsoft shares could move even higher as the company's commercial and public cloud business drive growth.
WFC Wells Fargo
$57.64

(0.00%)

07/16/18
BMOC
07/16/18
NO CHANGE
Target $61
BMOC
Market Perform
Wells Fargo price target raised to $61 at BMO Capital after in-line Q2
BMO Capital analyst James Fotheringham kept his Market Perform rating and nudged his price target on Wells Fargo (WFC) to $61 from $59 after the company's in-line Q2 "core" results which also showed higher than expected net interest margins and lower loss provisions. The analyst notes that after relative underperformance by the financials sector this year, he would recommend that investors buy "inexpensive stocks with near-term catalysts", including Santander (SC), OneMain (OMF), and Synchony (SYF).
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).
07/15/18
KBWI
07/15/18
UPGRADE
Target $63
KBWI
Outperform
Wells Fargo upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded Wells Fargo to Outperform and raised his price target for the shares to $63 from $57. The stock closed Friday down 67c to $55.36. Current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term, Kleinhanzl tells investors in a research note. The analyst saw enough in Wells Fargo's most recent quarter to get him more constructive. He raised his earnings estimates and sees additional upside if management can drive expenses toward the company's investor day simulation range of $50B-$51B in 2020. Kleinhanzl sees expense saves and capital returns driving shares of Wells Fargo higher.
07/16/18
07/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term. 2. VF Corp. (VFC) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he sees an attractive risk/reward profile at current share levels given the company's "multi-year inflection." 3. UPS (UPS) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying the combination of cost and productivity improvements, coupled with a constructive" revenue backdrop, provide potential for improved Domestic Package margin performance and stronger operating income growth in 2019 for UPS. 4. Autoliv (ALV) upgraded to Outperform from Neutral at Daiwa. 5. Saratoga Investment (SAR) upgraded to Buy from Neutral at Compass Point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GOOGL Alphabet Class A
$1,248.76

(0.00%)

08/07/18
MSCO
08/07/18
NO CHANGE
Target $1325
MSCO
Overweight
Enterprise value of Alphabet's Waymo raised to $175B at Morgan Stanley
Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, namely logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Partnerships with Walmart (WMT), DDR (DDR) and Peterbilt speak to Waymo's logistics focus, said Nowak, who sees the company potentially having a $90B logistics business. Additionally, he sees a roughly $7B licensing opportunity, pointing to the company's FCA (FCAU) relationship as a model of how companies could pay a license fee to Waymo for its autonomous technology. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares.
08/07/18
08/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS ZILLOW TO NEUTRAL: BofA Merrill Lynch analyst Nat Schindler downgraded Zillow (Z, ZG) to Neutral from Buy and cut its price target to $60 from $70 following the Q2 report and reduction in guidance. Schindler said the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook was cut, and other revenue also missed, indicating the new construction opportunity is also taking longer to materialize. Zillow Class A shares are down about 17% in late morning trading. MORGAN STANLEY SAYS WAYMO COULD BE WORTH $175B: Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's (GOOG, GOOGL) Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares. GOLDMAN RAISES NVIDIA TARGET AHEAD OF EARNINGS: Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat Street estimates and raised guidance, the analyst expects a "noisy" quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining, and potential disruption from the virus attack at TSMC (TSM). That said, Hari noted that his long-term bull thesis on Nvidia remains intact and reiterated a Buy rating on the shares. ARGUS CUTS CBS TO HOLD: Argus analyst Joseph Bonner downgraded CBS (CBS) to Hold from Buy, noting significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIA, VIAB) merger. Bonner noted that if the Moonves allegations are proven true, he would be immediately dismissed, which could end the board's bid to remain independent and thereby inflict damage on the shareholders.
GOOG Alphabet
$1,235.10

(0.00%)

BLMN Bloomin' Brands
$18.13

(0.00%)

07/17/18
07/17/18
UPGRADE

Outperform
Bloomin' Brands upgraded to Outperform from Market Perform at Raymond James
As previously reported, Raymond James upgraded Bloomin' Brands to Outperform from Market Perform and established a $25 price target. Analyst Brian Vaccaro said the 20% decline in shares since early May reflects reduced expectations related to Brazil and provides an attractive entry point given his outlook for strong US Outback comps.
07/17/18
07/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Buy from Hold at Stifel and to Outperform from Market Perform at BMO Capital. 2. Wolverine World Wide (WWW) upgraded to Strong Buy from Buy at CL King. 3. Fidelity National (FNF) and First American (FAF) upgraded to Outperform from Market Perform at Keefe Bruyette. 4. Bloomin' Brands (BLMN) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Vaccaro saying the 20% decline in shares since early May reflects reduced expectations related to Brazil and provides an attractive entry point given his outlook for strong U.S. Outback comps. 5. Restaurant Brands (QSR) upgraded to Outperform from Market Perform at Cowen with analyst Andrew Charles saying he believes Tim Horton sales have bottomed and cited upcoming drivers such as its debt capacity that could be used for M&A and expectations for unit growth to outpace consensus. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/17/18
RAJA
07/17/18
UPGRADE
RAJA
Outperform
Bloomin' Brands upgraded to Outperform from Market Perform at Raymond James
07/17/18
TIGR
07/17/18
NO CHANGE
TIGR
Buy
Current pullback in Bloomin' Brands a buying opportunity, says Tigress Financial
Tigress Financial analyst Ivan Feinseth kept his Buy rating on Bloomin' Brands, saying the company continues to "benefit from the strong consumer spending environment and positive casual dining trends, along with a number of existing catalysts that could unlock additional shareholder value". With same store sales growth gaining momentum, the analyst notes the company's efforts to invest in new initiatives to further improve operating margins. Feinseth contends that "further upside exists from current levels", recommending that investors use the recent pullback in the stock price as a buying opportunity.
NOC Northrop Grumman
$292.10

(0.00%)

07/31/18
BOFA
07/31/18
NO CHANGE
BOFA
General Dynamics added to US 1 List, Northrop Grumman removed at BofA/Merrill
07/31/18
07/31/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Neutral from Reduce at Nomura Instinet analyst Mark Kelley saying after selling off 27% since the Q2 earnings report on July 27, expectations have been appropriately reset. 2. Chipotle (CMG) upgraded to Buy from Hold at Jefferies with analyst Andy Barish saying he believes Chipotle is one of the better positioned companies to benefit from the ongoing shift to digital/off-premise. 3. Affiliated Managers (AMG) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Robert Lee saying he believes the company is positioned for "at least" modest organic growth. 4. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the Q1 report was "stellar," beating every key metric, while the share reaction was "lukewarm." 5. Northrop Grumman (NOC) upgraded to Buy on valuation at Buckingham with analyst Richard Safran saying the sell-off following the Q2 report provides an investment opportunity telling investors Defense spending and recent program wins may not be fully reflected in consensus expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/27/18
FBCO
07/27/18
NO CHANGE
Target $326
FBCO
Neutral
Northrop Grumman price target cut to $326 from $341 at Credit Suisse
Credit Suisse analyst Robert Springarn maintained a Neutral rating on Northrop Grumman but cut his price target to $326 after the company reported "in line" quarterly results, but surprised investors with forward-losses in three of its segments. In a research note to investors, Springarn says he thinks Northrop Grumman will ultimately overcome its issues, as management expressed confidence on the Q2 call that it will return to "strong performance in short order" and he expects the market will monitor performance "a bit more closely" near-term. Springarn says he is content to remain on the sidelines for now.
07/31/18
BUCK
07/31/18
UPGRADE
BUCK
Buy
Northrop Grumman upgraded to Buy on valuation at Buckingham
Buckingham analyst Richard Safran upgraded Northrop Grumman to Buy from Neutral and increased its price target to $371 from $246. Safran said the sell-off following the Q2 report provides an investment opportunity telling investors Defense spending and recent program wins may not be fully reflected in consensus expectations.
KDP Keurig Dr Pepper
$23.75

(0.00%)

07/16/18
RBCM
07/16/18
NO CHANGE
Target $75
RBCM
Outperform
Monster Beverage price hike to come November 1st, says RBC Capital
RBC Capital analyst Nik Modi says his industry sources have confirmed that Monster Beverage (MNST) intends to raise its prices by 4.0-5.5% on November 1st depending on the pack size, which would be in line with the management's indication of pricing review made at the June shareholder meeting. The analyst keeps his Outperform rating and $75 price target on Monster, adding that Coca Cola (KO), PepsiCo (PEP) and Keurig Dr Pepper (KDP) will also likely make pricing changes in response over the coming months.
07/25/18
07/25/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Snap (SNAP) upgraded to Mixed from Negative at Vertical Group with analyst Phil Leggiere citing expectations for strong 2H 2018 spending. 2. Keurig Dr Pepper (KDP) upgraded to Positive from Neutral at Susquehanna. 3. Lockheed Martin (LMT) upgraded to Outperform from Market Perform at Cowen with analyst Cai von Rumohr citing its enhanced visibility to roughly 10% growth through 2021, above average cash flow, dividend yield, and attractive risk/reward. 4. Hawaiian Holdings (HA) upgraded to Buy from Hold at Deutsche Bank with analyst Michael Linenberg saying he views last night's quarter as strong and sees an improving CASM trend. 5. Target (TGT) upgraded to Accumulate from Hold at Gordon Haskett with analyst Chuck Grom saying geolocation data and proprietary card data support his Q2 4.5% comp. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/24/18
SUSQ
07/24/18
UPGRADE
SUSQ
Positive
Keurig Dr Pepper upgraded to Positive from Neutral at Susquehanna
07/18/18
GSCO
07/18/18
INITIATION
Target $26
GSCO
Neutral
Keurig Dr Pepper reinstated with a Neutral at Goldman Sachs
Goldman analyst Judy Hong reinstated Keurig Dr Pepper with a Neutral and $26 price target citing valuation.
WRK WestRock
$54.73

(0.00%)

07/05/18
SPHN
07/05/18
NO CHANGE
SPHN
Equal Weight
WestRock, International Paper price targets cut at Stephens
Stephens analyst Mark Connelly lowered his price target on WestRock (WRK) to $63 from $74 and cut his target for International Paper (IP) to $57 from $66 as he sees the two bearing the burden of maintaining market balance as he expects high containerboard prices to encourage a growing number of capacity additions. Connelly, who now projects about 3% capacity growth annually for the industry through 2022, believes Packaging Corp. (PKG) should trade at a significant premium as he sees it having multiple internal conversion prospects. He maintains Equal Weight ratings on WestRock and International Paper and an Overweight rating on Packaging Corp.
05/17/18
KEYB
05/17/18
NO CHANGE
KEYB
Graphic Packaging announced another price increase, says KeyBanc
After successfully raising coated recycled paperboard prices by $50 per ton in February-March, Graphic Packaging (GPK) announced another $50 per ton increase yesterday effective June 15, KeyBanc analyst Adam Josephson tells investors in a research note, citing RISI. Sources told RISI that WestRock (WRK) is likely to also announce a $50 per ton increase for June, the analyst adds. Josephson believes boxboard industry conditions are "quite healthy at the moment."
02/08/18
DBAB
02/08/18
DOWNGRADE
Target $35
DBAB
Hold
KapStone downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Debbie Jones downgraded KapStone Paper & Packaging (KS) to Hold to reflect the takeover by WestRock (WRK). The analyst raised her price target for the shares to $35 from $29. She points out that WestRock management "quickly dismissed" concerns over potential antitrust issues.
05/29/18
SPHN
05/29/18
NO CHANGE
SPHN
Nine Dragons deal increases uncertainty in containerboard market, says Stephens
Stephens analyst Mark Connelly noted that private Canadian printing paper and pulp producer Catalyst Paper agreed to sell its Maine and Wisconsin softwood paper mills to China's Nine Dragons, which he sees increasing uncertainty in the containerboard market and likely to further reduce investor interest in the space. Among companies in the space, Connelly currently recommends only Packaging Corp. (PKG). Others in the space include International Paper (IP), KapStone (KS), Domtar (UFS) and WestRock (WRK).
CI Cigna
$181.78

(0.00%)

08/03/18
RHCO
08/03/18
NO CHANGE
Target $244
RHCO
Buy
Cigna price target raised to $244 from $220 at SunTrust
SunTrust analyst David MacDonald raised his price target on Cigna (CI) to $244 and kept his Buy rating after its "strong" Q2 results showed a "sizable" earnings beat across its business lines and lower expected medical cost trends. The analyst also maintains his bullish view on the pending Express Scripts (ESRX) deal, stating that the potential benefits of the combination are underappreciated give the strong momentum of the latter heading into 2019. MacDonald contends that investors' merger related concerns are "misplaced" and also sees Cigna valuation as "compelling".
08/02/18
JPMS
08/02/18
NO CHANGE
JPMS
Overweight
Cigna holders unlikely to vote down Express Scripts deal, says JPMorgan
While Cigna (CI) shares have underperformed peers since the deal for Express Scripts (ESRX) was announced in March, shareholders are unlikely to vote down the transaction, JPMorgan analyst Gary Taylor tells investors in a research note after the Wall Street Journal reported that Carl Icahn has built a stake and will push for voting against the deal. The analyst admits the market is taking a more negative view, as Express Scripts' 16% spread to offer value widened to 25% yesterday. Taylor believes few shareholders have questioned the strategic rational of the merger. He believes, however, that some of Icahn's points could resonate with bears in the near-term. The analyst keeps an Overweight rating on Cigna.
08/02/18
SBSH
08/02/18
NO CHANGE
SBSH
Vote against Express Scripts deal 'somewhat shortsighted,' says Citi
Citi analyst Ralph Giacobbe believes a vote against Cigna's (CI) proposed acquisition of Express Scripts (ESRX), which the Wall Street Journal reported that activist Carl Icahn will push for, could prove "somewhat shortsighted given the changing and evolving healthcare landscape and the integrated offering and cash flow that a combined entity would generate to compete more effectively." The analyst says that regardless of the outcome, he remains positive on Cigna shares. The company's model should continue to drive growth without Express Scripts, and potentially enhance growth with the deal, Giacobbe tells investors in a research note. He keeps a Buy rating on Cigna.
08/07/18
LEHM
08/07/18
NO CHANGE
LEHM
Overweight
Cigna shares have upside with deal or no deal, says Barclays
Barclays analyst Steve Valiquette sees upside in shares of Cigna (CI) no matter the outcome of the shareholder vote on August 24 relating to its proposed acquisition of Express Scripts (ESRX). Under a deal break scenario, Cigna should trade at a multiple relatively in-line to diversified peer Anthem (ANTM), implying a fair value of $215, Valiquette tells investors in a research note. If the deal is approved, the analyst sees Cigna shares falling to $180 in the near term. However, his sum-of-the-parts analysis yields a current fair value of $213 per share. As such, the analyst sees upside potential on Cigna in both merger vote scenarios. Valiquette keeps an Overweight rating on the shares.
EA Electronic Arts
$131.29

(0.00%)

08/01/18
08/01/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoZone (AZO) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker saying Improving comps and fundamentals, coupled with a stock that has underperformed year-to-date, has brought a "compelling" valuation. 2. Pandora (P) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying the company's double-digit organic revenue growth and declining EBITDA losses were driven by improving execution, adding that while the 2% active listener hours decline is a worry, the valuation on the stock is "undemanding" given its expected annualized revenue growth of about 10% over the next 3 years. 3. Papa John's (PZZA) upgraded to Buy from Hold at Jefferies with analyst Alexander Slagle saying the stock, down 50% from highs, now reflects the likelihood that fundamentals will get worse before improving. 4. Electronic Arts (EA) upgraded to Buy from Hold at Argus with analyst Joseph Bonner saying the latest pullback in the stock price after the company's recent Q1 earnings report offers a favorable entry point. 5. Sarepta (SRPT) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Matthew Harrison saying the stock is down about 34% since June 19 after having moved up by about 50% when its initial DMD gene therapy data was announced. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/01/18
ARGS
08/01/18
UPGRADE
ARGS
Buy
Electronic Arts upgraded to Buy from Hold at Argus
08/01/18
ARGS
08/01/18
UPGRADE
Target $155
ARGS
Buy
Electronic Arts upgraded to Buy from Hold at Argus
Argus analyst Joseph Bonner upgraded Electronic Arts to Buy from Hold with a price target of $155, saying the latest pullback in the stock price after the company's recent Q1 earnings report offers a favorable entry point. Bonner states that while the videogame industry is dominated by the success of Fortnite, Electronic Arts will have a relatively stronger performance in the September and December quarters thanks to the expected launch of its new titles that includes Battlefield V.
08/10/18
PIPR
08/10/18
NO CHANGE
Target $165
PIPR
Overweight
Early review scores of EA's Madden modestly above last year, says Piper Jaffray
Piper Jaffray analyst Michael Olson noted that the current average "metacritic" review score for Electronic Arts' Madden '19 is 83.5, which is above the 82 rating for last year's version of the game and higher than the 10-year average of 82 for the series. He remains comfortable with his forecast for flat year-over-year unit sales of 5.5M for Madden, but believes the uptick in average review score might offer modest upside. Olson keeps an Overweight rating and $165 price target on EA shares.
A Agilent
$65.95

(0.00%)

06/28/18
JPMS
06/28/18
DOWNGRADE
Target $105
JPMS
Underweight
JPMorgan downgrades Varian to Underweight following period of restriction
JPMorgan analyst Tycho Peterson downgraded Varian Medical Systems (VAR) to Underweight from Neutral following a period of restriction. Persistent order growth volatility, a "sluggish" end market and in the near-term and risk from the U.S.-China trade war weigh on the analyst's longer-term outlook for the stock. Varian has a dominant franchise but a mature industry and premium valuation are hard to overlook, Peterson tells investors in a research note. The analyst sees better risk/rewards in other parts of his coverage universe, including tool names Agilent (A), Danaher (DHR) and Thermo Fisher (TMO).
06/08/18
BARD
06/08/18
NO CHANGE
Target $77
BARD
Outperform
Agilent recent weakness a buying opportunity, says Baird
Baird analyst Catherine Ramsey Schulte attended Agilent's analyst day and said her positive outlook on the company remains unchanged. She continues to expect strong core growth and margin expansion to help drive above market performance over the next several years. Schulte said she would use recent weakness as a buying opportunity and reiterated her Outperform rating and $77 price target on Agilent shares.
05/15/18
COWN
05/15/18
UPGRADE
COWN
Outperform
Agilent upgraded to Outperform from Market Perform at Cowen
05/15/18
JEFF
05/15/18
NO CHANGE
Target $80
JEFF
Buy
Agilent pullback a buying opportunity, says Jefferies
Jefferies analyst Brandon Couillard recommends using the post-earnings pullback in shares of Agilent Technologies as a buying opportunity. Guidance was maintained, despite dilution from Lasergen, and does not yet capture accretion from the pending AATI deal, Couillard tells investors in a research note. He sees no reason to alter his positive thesis and keeps a Buy rating on Agilent with a slightly reduced price target of $80.
AAPL Apple
$208.87

(0.00%)

08/01/18
BTIG
08/01/18
NO CHANGE
Target $235
BTIG
Buy
Apple price target raised to $235 from $207 at BTIG
BTIG analyst Walter Piecyk, in a note published last night, raised his price target on Apple (AAPL) shares to $235 from $207, stating that he believes there are early signs that upgrade rates might be bottoming and noting that iPhone revenue grew by over 20% despite "historic low" upgrade rates in Q3. Apple CEO Tim Cook hinted at a noteworthy content project, added Piecyk, who agrees with fellow BTIG analyst Rich Greenfield's view that Apple is likely to follow Netflix (NFLX) and Amazon's (AMZN) approach "build their way into the market rather than buy their way in" to video. Piecyk keeps a Buy rating on Apple shares.
08/09/18
JPMS
08/09/18
NO CHANGE
JPMS
Neutral
Lumentum selloff provides attractive entry point, says JPMorgan
JPMorgan analyst Samik Chatterjee believes the post-earnings pullback in shares of Lumentum (LITE) provides an attractive entry point. However, he keeps a Neutral rating on Lumentum with an $80 price target. The shares sold off yesterday as management chose to provide conservative 3D Sensing revenue guidance for fiscal Q2 ahead of greater visibility into market share development and inventory position with its primary customer, Apple (AAPL), on next generation phones expected to be launched in September, Chatterjee tells investors in a research note. Based on his conversations with management, Chatterjee believes the softer guide is driven entirely by a lower market share assumption and budgeting for inventory timing "purely out of conservatism." This increases the likelihood of an upside surprise, the analyst contends.
08/02/18
SBSH
08/02/18
NO CHANGE
Target $5
SBSH
Sell
Citi reiterates Sell on Fitbit, says not an acquisition target
Citi analyst Jim Suva reiterates a Sell rating on Fitbit (FIT) with a $5 price target following the company's Q2 results, which he notes were largely better than expected except for a decline in free cash flow. Apple's (AAPL) smart watch is smarter than Fitbit's (FIT) smartwatches, which do not allow "robust" two-way communication or a lengthy app catalog, and the price differential is immaterial, Suva tells investors in a post-earnings research note. Further, he does not see Fitbit as an acquisition target.
TIF Tiffany
$130.88

(0.00%)

07/16/18
LOOP
07/16/18
NO CHANGE
Target $150
LOOP
Buy
Tiffany price target raised to $150 from $134 at Loop Capital
Loop Capital analyst Laura Champine raised her price target on Tiffany to $150 and kept her Buy rating following an update to her model, citing the company's improved growth prospects following the redesign of its product. The analyst adds that there is still an opportunity to update Tiffany's store appearance, but notes that her estimate for FY18 comps of up 6.1% is already the highest growth rate the company posted since 2011.
07/09/18
BOFA
07/09/18
NO CHANGE
BOFA
Tiffany removed from US 1 List at BofA/Merrill
08/10/18
OPCO
08/10/18
DOWNGRADE
Target $145
OPCO
Perform
Tiffany downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Brian Nagel downgraded Tiffany to Perform with an unchanged price target of $145. The analyst continues to look "very favorably" upon the company's longer-term prospects, however, he's concerned that recent shifts in global currencies could weigh on its domestic sales to foreign tourists and "knock shares from now peakish valuations." Nagel looks at $120-$125 as near-term support for Tiffany shares.
06/25/18
GSCO
06/25/18
INITIATION
GSCO
Sell
PVH Corp. initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Alexandra Walvis initiated PVH Corp (PVH) with a Sell, telling investors in a research note that while the company has benefited from a strong acceleration in growth in Tommy Hilfiger and Calvin Klein, she believes momentum is peaking as a number of tailwinds fade. This morning, Walvis also initiated shares of Tapestry (TPR) with a Conviction Buy and Tiffany (TIF) and VFC (VFC) with a Buy.
LRCX Lam Research
$178.13

(0.00%)

08/09/18
08/09/18
DOWNGRADE
Target $54

Equal Weight
Morgan Stanley more cautious on semi equipment, downgrades Applied Materials
As previously reported, Morgan Stanley analyst Joseph Moore downgraded Applied Materials (AMAT) to Equal Weight from Overweight, as he said he is concerned by the fact that the certainty of semiconductor capital equipment vendors "seems much higher than the conviction of the spenders." He would expect Applied Materials to express a sense of optimism about the recovery when it reports earnings next week, similar to the June quarters from equipment vendors, which he said should help the stock. However, Moore views the first quarter of 2018 as the peak and forecasts declines of about 10% next year. He lowered his price target on Applied shares to $54 from $58. Moore, who sees equipment stocks as more range-bound for the next 6-12 months, also lowered his semiconductor capital equipment industry view to In-Line from Attractive.
07/27/18
UBSW
07/27/18
NO CHANGE
Target $220
UBSW
Buy
Lam Research quarter marks the bottom, says UBS
UBS analyst Timothy Arcuri noted Lam Research is enduring a healthy correction, but he believes this quarter marked the bottom. Arcuri sees s snap back in revenue moving forward and reiterated his Buy rating and $220 price target on Lam Research shares.
08/06/18
STFL
08/06/18
NO CHANGE
STFL
Stifel says Applied, Lam to be beneficiaries of NAND capital intensity step-up
Ahead of this week's upcoming Flash Memory Summit, Patrick Ho shared his view of how he expects capital intensity trends continue to increase as the NAND industry moves to 96 layers and above over the next few years. From a stocks perspective, he believes the biggest beneficiaries of the step-up will remain Applied Materials (AMAT) and Lam Research (LRCX), while also noting that MKS Instruments (MKSI) can benefit from its leadership position in many areas where it supplies both Applied and Lam. Stating that he supports Ho's view on the memory industry's increasing capital intensity, Stifel analyst Kevin Cassidy said in his own note to investors that he expects FMS conference keynotes to discuss the expanding markets for NAND Flash pushing total revenue and profits up despite the industry's increasing capital expenditures driving average selling prices lower. Cassidy also noted the first ever MRAM Developers Day will be held Monday, August 6, stating that he views this as significant for expanding the MRAM eco-system led by Everspin (MRAM). Other NAND Flash names Cassidy has previously been positive about include Micron (MU) and Smart Global (SGH).
08/13/18
STFL
08/13/18
NO CHANGE
STFL
Buy
3D NAND benefits equipment suppliers, advanced materials, says Stifel
Stifel analyst Patrick Ho tells investors in a research note that, following last week's Flash Memory Summit, the transition by the NAND industry to 96 layers and above will be the catalyst for a further step up in capital intensity trends for materials-enabled processes. He believes the comments and presentations that emerged from the conference continue to support his favorable view on names like Applied Materials (AMAT), KLA-Tencor (KLAC), Lam Reserach (LRCX) and MKS Instruments (MKSI), but believes another group that will benefit are materials/chemistries companies like Entegris (ENTG) and Versum Materials (VSM).
HDS HD Supply
$43.72

(0.00%)

04/06/18
DBAB
04/06/18
INITIATION
Target $45
DBAB
Buy
HD Supply resumed with a Buy at Deutsche Bank
Deutsche Bank analyst Karen Lau resumed coverage of HD Supply with a Buy rating and $45 price target. The analyst believes investor skepticism following the company's operational and cost issues creates a favorable risk/reward for the shares.
03/19/18
GSCO
03/19/18
INITIATION
Target $41
GSCO
Neutral
HD Supply assumed with a Neutral at Goldman Sachs
Goldman Sachs analyst Evelyn Chow assumed coverage of HD Supply Holdings with a Neutral rating and $41 price target. The analyst sees several near-term headwinds for the company and believes now is not the right time to own the shares. Chow initiated the Industrial Distributors sector with a neutral stance.
06/06/18
WELS
06/06/18
NO CHANGE
Target $50
WELS
Outperform
HD Supply price target raised to $50 from $45 at Wells Fargo
Wells Fargo analyst Allison Poliniak-Cusic raised her price target for HD Supply to $50 from $45 after the company reported a "solid" quarter to kick off FY18, especially considering the tough inflationary environment. The analyst reiterates an Outperform rating on the shares.
06/27/18
WOLF
06/27/18
INITIATION
Target $51
WOLF
Outperform
HD Supply initiated with an Outperform at Wolfe Research
Wolfe Research initiated HD Supply with an Outperform and price target of $51.
ADSK Autodesk
$133.41

(0.00%)

05/15/18
MSCO
05/15/18
NO CHANGE
Target $160
MSCO
Overweight
Autodesk price target raised to $160 from $150 at Morgan Stanley
Morgan Stanley analyst Keith Weiss said he now has greater confidence in billings growth at Autodesk after doing a "deep dive" on the primary drivers of its long-term subscription growth. Citing his new analyst, Weiss raised his price target on Autodesk to $160 and maintains an Overweight rating on the stock.
05/25/18
JPMS
05/25/18
NO CHANGE
Target $150
JPMS
Overweight
Autodesk results solid on most important metric, says JPMorgan
"Noisy" metrics like net subscriptions do not tell a clear story about the health of Autodesk's subscription transition in its Q1 results, JPMorgan analyst Sterling Auty tells investors in a post-earnings research note. Annualized recurring revenue is the most important metric and the results were solid in the quarter, the analyst contends. He says total ARR and subscription ARR were better than anticipated with some ASC 606 impacts. However, the billings 606 headwind should wain through the year as cash flow generation is forecasted to return, Auty contends. He keeps an Overweight rating on Autodesk with a $150 price target.
05/25/18
BREN
05/25/18
NO CHANGE
Target $168
BREN
Buy
Autodesk post-earnings pullback would be buying opportunity, says Berenberg
Berenberg analyst Gal Munda said Autodesk's first quarter came in fairly in-line with expectations, stating that he expects average recurring revenue growth to continue being driven by improvement in ARPS for the rest of the year. While he notes net new additions in the subscriber base were below consensus, Munda said this is in keeping with the company's previously outlined "higher quality sub" strategy. The analyst, who recommends using any post-earnings pullback as a buying opportunity, keeps a Buy rating and $168 price target on Autodesk shares.
08/07/18
GUGG
08/07/18
INITIATION
Target $150
GUGG
Neutral
Autodesk resumed with a Neutral at Guggenheim
Guggenheim analyst Ken Wong resumed coverage of Autodesk with a Neutral rating and $275 price target. Guggenheim had a Buy rating on the shares under a different analyst before suspending coverage of the company April.
BSX Boston Scientific
$33.30

(0.00%)

08/08/18
ADAM
08/08/18
NO CHANGE
Target $39
ADAM
Buy
Boston Scientific estimates have upside potential on Lotus, says Canaccord
Canaccord Genuity analyst Jason Mills points out that Boston Scientific this morning announced that it will be in position to submit the final Lotus Edge premarket approval next week, with plans to be back in Europe in Q1 of 2019. The pending market re-entry of Lotus could drive "meaningful upside" to consensus expectations, especially in 2020 and beyond, Mills tells investors in a research note. He believes Lotus Edge has largely been taken out of forward estimates and keeps a Buy rating on Boston Scientific with a $39 price target.
07/26/18
ADAM
07/26/18
NO CHANGE
Target $39
ADAM
Buy
Still a great time to invest in Boston Scientific, says Canaccord
Canaccord analyst Jason Mills said Q2 represented another stellar quarter for Boston Scientific. He said it is still a great time to invest in the company as management raised guidance and he favors the long-term strategy to deliver organic growth via technology differentiation and global breadth in targeted med-tech markets. Mills reiterated his Buy rating and raised his price target to $39 from $36 on Boston Scientific shares.
08/08/18
PIPR
08/08/18
NO CHANGE
Target $40
PIPR
Overweight
Boston Scientific target raised to $40 on Lotus Edge news at Piper Jaffray
Boston Scientific announced this morning that it would be submitting the final technical module to the FDA next week on its Lotus Edge Aortic valve, Piper Jaffray analyst Matt O'Brien tells investors in a research note. This is "clearly a positive" for the product's outlook as management stated that they would either announce the submission of the module or a decision not to proceed with the device, the analyst adds. He believes the submission signals management's confidence in obtaining regulatory approval for the device. O'Brien raised his price target for Boston Scientific to $40 from $38 and continues to recommend the stock with an Overweight rating.
07/25/18
PIPR
07/25/18
NO CHANGE
Target $38
PIPR
Overweight
Boston Scientific price target raised to $38 from $32.50 at Piper Jaffray
Piper Jaffray analyst Matt O'Brien raised his price target on Boston Scientific to $38 after its better than expected Q2 results. The analyst notes that the quarter was "balanced across business segments and geographies with Rhythm Management", adding that the management also narrowed higher its FY18 organic growth rate targets. O'Brien also cites another quarter of strength in the emerging markets, keeping his Overweight rating on expectations of "expanded product indications, clinical data in Q3, and the successful integration of several new acquisitions".
ZBH Zimmer Biomet
$122.45

(0.00%)

08/13/18
NEED
08/13/18
NO CHANGE
Target $150
NEED
Buy
Needham downgrades Zimmer to Buy, upgrades Medtronic to Strong Buy
Needham analyst Micheal Matson downgraded Zimmer Biomet (ZBH) to Buy from Strong with a price target of $150. The analyst also upgraded Medtronic (MDT) to Strong Buy from Buy and raised his price target for the shares to $119 from $103. On Zimmer, the analyst cites lower growth potential and valuation for taking his rating to Buy. For Medtronic, Matson expects a strong product cycle and sees potential upside to consensus estimates.
08/08/18
08/08/18
DOWNGRADE

Neutral
Smith & Nephew downgraded to Neutral on lack of robotic share gain at UBS
As previously reported, UBS analyst Ian Douglas-Pennant downgraded Smith & Nephew to Neutral from Buy and lowered his price target on the stock to 1340p from 1470p. Growth acceleration from S&N's Navio robot hasn't materialized and he now believes his initial assumption of S&N's share of the market was too positive. He also cites the upcoming launch of a competitor from Zimmer Biomet (ZBH).
08/13/18
NEED
08/13/18
DOWNGRADE
NEED
Buy
Zimmer Biomet downgraded to Buy from Strong Buy at Needham
08/13/18
NEED
08/13/18
DOWNGRADE
NEED
Buy
Needham downgrades Zimmer Biomet to Buy, still sees 22% upside
Needham analyst Mike Matson downgraded Zimmer Biomet to Buy from Strong Buy with a $150 price target, which implies 22% upside from current share levels. The downgrade reflects slower orthopedic market growth, the need for portfolio management to drive higher revenue growth, and Zimmer's need for reinvestment which is likely to weigh on margins, Matson tells investors in a research note. He notes the company's orthopedic market growth has slowed since it encountered its initial quality issues. The analyst believes portfolio management can allow Zimmer to increase its revenue growth, but he expects this to take several years.
JACK Jack in the Box
$89.03

(0.00%)

05/07/18
05/07/18
DOWNGRADE

Mixed
Follow-up: Jack in the Box downgraded to Mixed on competition at OTR Global
As previously reported, OTR Global downgraded Jack in the Box to Mixed from Positive. The firm's checks with managers indicate increased competition and a mixed response to the Cholula Buttery Jack is pressuring transactions and sales.
05/10/18
SPHN
05/10/18
NO CHANGE
Target $120
SPHN
Overweight
GrubHub deal with Jack in the Box 'one of many to come,' says Stephens
After GrubHub (GRUB) announced a partnership to provide delivery for hundreds of Jack in the Box (JACK) locations, Stephens analyst Will Slabaugh noted that the deal is not exclusive but he believes it will be "one of many to come" for GrubHub with large national chains. He maintains an Overweight rating and $120 price target on GrubHub shares.
05/18/18
RHCO
05/18/18
NO CHANGE
Target $100
RHCO
Buy
Jack in the Box price target lowered to $100 from $110 at SunTrust
SunTrust analyst Jake Bartlett lowered his price target on Jack in the Box to $100 after the company's lowered FY18 SSS forecast, saying it adds uncertainty to the prospects of recovery in comps on top of the uncertainty around cost savings. Longer term, Bartlett keeps his Buy rating despite the increased risk, noting that its free cash flow yield per share of 7.7% is attractive while its post Qdoba-sale and refranchising investment story is "compelling".
07/11/18
WEDB
07/11/18
NO CHANGE
Target $115
WEDB
Outperform
Jack in the Box added to Best Ideas List at Wedbush
Wedbush analyst Nick Setyan added Jack in the Box to his firm's Best Ideas List, while reiterating an Outperform rating and $115 price target on the stock. The analyst views the combination of long-term same-store sales growth, margin, and free cash flow guidance, expected in August, and incremental visibility into short- and medium-term same-store sales growth drivers, beginning with solid Q4 same-store sales growth guidance, to result in an upward revaluation of shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
12/13/18
12/13
15:17
12/13/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
12/13/18
12/13
15:16
12/13/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.80

0.7 (1.06%)

15:11
12/13/18
12/13
15:11
12/13/18
15:11
Hot Stocks
Starbucks says starting new rewards program in China »

Starbucks executives…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

FFIN

First Financial

$60.53

-0.8 (-1.30%)

15:08
12/13/18
12/13
15:08
12/13/18
15:08
Hot Stocks
First Financial elects John Ruzicka Chief Information Officer »

First Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

RDNT

RadNet

$12.61

0.05 (0.40%)

15:08
12/13/18
12/13
15:08
12/13/18
15:08
Hot Stocks
RadNet and MemorialCare expand joint venture »

MemorialCare and RadNet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:05
12/13/18
12/13
15:05
12/13/18
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SFLY

Shutterfly

$43.18

-1.65 (-3.68%)

15:04
12/13/18
12/13
15:04
12/13/18
15:04
Recommendations
Shutterfly analyst commentary  »

Shutterfly weakness…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$35.90

5.835 (19.41%)

15:04
12/13/18
12/13
15:04
12/13/18
15:04
Recommendations
Health Insurance Innovations analyst commentary  »

Settlement should remove…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

COST

Costco

$225.93

-1.89 (-0.83%)

15:04
12/13/18
12/13
15:04
12/13/18
15:04
Options
Costco options imply 5.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HIIQ

Health Insurance Innovations

$35.90

5.835 (19.41%)

15:02
12/13/18
12/13
15:02
12/13/18
15:02
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MRVL

Marvell

$15.53

0.18 (1.17%)

15:00
12/13/18
12/13
15:00
12/13/18
15:00
Options
Size time spread in Marvell Tech following an analyst upgrade »

Size time spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 08

    Jan

G

Genpact

$28.14

-0.27 (-0.95%)

, EXLS

ExlService

$55.76

0.13 (0.23%)

14:57
12/13/18
12/13
14:57
12/13/18
14:57
Conference/Events
William Blair IT/BPO services analysts to hold analyst/industry conference call »

India IT/BPO Services…

G

Genpact

$28.14

-0.27 (-0.95%)

EXLS

ExlService

$55.76

0.13 (0.23%)

WNS

WNS Holdings

$46.99

-0.82 (-1.72%)

GLOB

Globant

$55.66

-1.37 (-2.40%)

PRFT

Perficient

$23.49

-0.28 (-1.18%)

VRTU

Virtusa

$41.05

1.2 (3.01%)

INFY

Infosys

$9.85

0.19 (1.97%)

WIT

Wipro

$5.30

0.19 (3.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.61

0.51 (0.77%)

14:56
12/13/18
12/13
14:56
12/13/18
14:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says 80% of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

AAPL

Apple

$170.45

1.36 (0.80%)

, INTC

Intel

$48.11

0.28 (0.59%)

14:55
12/13/18
12/13
14:55
12/13/18
14:55
Recommendations
Apple, Intel analyst commentary  »

Lynx questions…

AAPL

Apple

$170.45

1.36 (0.80%)

INTC

Intel

$48.11

0.28 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

SBUX

Starbucks

$66.48

0.38 (0.57%)

14:50
12/13/18
12/13
14:50
12/13/18
14:50
Options
Heavy trading in Starbucks Weekly options during the company's Investor Day »

Heavy trading in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

ADBE

Adobe

$247.50

2.06 (0.84%)

14:49
12/13/18
12/13
14:49
12/13/18
14:49
Options
Adobe options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

CMG

Chipotle

$472.11

0.91 (0.19%)

, DANOY

Danone

$0.00

(0.00%)

14:44
12/13/18
12/13
14:44
12/13/18
14:44
Hot Stocks
Chipotle announces hiring of Chief Legal Officer and Chief Development Officer »

Chipotle Mexican Grill…

CMG

Chipotle

$472.11

0.91 (0.19%)

DANOY

Danone

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 14

    Dec

  • 06

    Feb

SBUX

Starbucks

$66.51

0.41 (0.62%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks says goal to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

GPX

GP Strategies

$13.13

0.06 (0.46%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Dec

TSLA

Tesla

$371.33

4.57 (1.25%)

, GOOG

Alphabet

$1,057.32

-6.24 (-0.59%)

14:41
12/13/18
12/13
14:41
12/13/18
14:41
Periodicals
Tesla's Vaish resigns to start company at Google's Area120, CNBC says »

Parag Vaish, head of…

TSLA

Tesla

$371.33

4.57 (1.25%)

GOOG

Alphabet

$1,057.32

-6.24 (-0.59%)

GOOGL

Alphabet Class A

$1,068.33

-5.33 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 03

    Mar

GPX

GP Strategies

$13.13

0.06 (0.46%)

14:40
12/13/18
12/13
14:40
12/13/18
14:40
Conference/Events
GP Strategies management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 18

    Dec

HIIQ

Health Insurance Innovations

$36.84

6.775 (22.53%)

14:40
12/13/18
12/13
14:40
12/13/18
14:40
Recommendations
Health Insurance Innovations analyst commentary  »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.50

-1.03 (-0.39%)

, SPX

S&P 500

$0.00

(0.00%)

14:36
12/13/18
12/13
14:36
12/13/18
14:36
General news
NYPD says monitoring multiple bomb threats, not considered credible »

The official Twitter of…

SPY

SPDR S&P 500 ETF Trust

$264.50

-1.03 (-0.39%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:35
12/13/18
12/13
14:35
12/13/18
14:35
General news
Saudi PIF has been a swing buyer of stocks »

Saudi PIF has been a…

SBUX

Starbucks

$66.43

0.33 (0.50%)

14:32
12/13/18
12/13
14:32
12/13/18
14:32
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks to expand nitro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.